Home » Topics » Conferences

Conferences
RSS

Comparative in vitro and in vivo activity of WQ-3034 reported at ICAAC

Sep. 28, 1998

Xoma presents new BPI-related findings and Neuprex phase II data at ICAAC

Sep. 28, 1998

Parasin I: new antimicrobial peptide produced by catfish

Sep. 28, 1998

More new azolylphenyl oxazolidinones in development at P&U

Sep. 28, 1998

Modifications to the linezolid molecule a focus of research at Pharmacia & Upjohn

Sep. 28, 1998

UCB's anticonvulsant drug levetiracetam is safe and effective in phase III trials

Sep. 28, 1998

P&U explores modifications to linezolid; new, more active oxazolidinones result

Sep. 25, 1998

Zanamivir results presented at ICAAC; two more regulatory filings announced

Sep. 25, 1998

In vitro and in vivo activity of S-34109 against Chlamydia and MRSA

Sep. 25, 1998

IB-643 more effective than AmB in treating systemic murine candidosis

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...